Health

WHO TB Report 2026: India's TB Deaths Fall 38% Since 2015

By Editorial Staff ·
Graphic on the WHO Global Tuberculosis Report 2026 and India's fall in TB deaths

The World Health Organization released its Global Tuberculosis Report 2026 on November 12, and the headline for India is a sharp fall in deaths. According to the report, TB mortality in India has dropped 38% since 2015, faster than the 35% decline recorded worldwide. Yet the same report shows India still has more TB patients than any other country, and WHO has warned that global progress on cutting new infections remains far behind target.

What the WHO Report Says About the World

TB is still the single infectious agent that kills the most people. WHO estimates that 10.6 million people fell ill with TB in 2025 and about 1.1 million died. The fall in deaths since 2015 means the world has finally reached the first mortality milestone of WHO’s End TB Strategy, though five years later than planned.

The picture on new cases is weaker. Incidence, which measures new cases per 100,000 people, has fallen only 14% since 2015, against a milestone of 50% for 2025. Thirty countries account for 88% of all people who developed the disease last year.

WHO Director-General Dr Tedros Adhanom Ghebreyesus called the continued decline in cases and deaths “very encouraging”, and urged countries to protect funding and widen access to services. The full findings are available on the WHO announcement of the 2026 report.

Key global numbers

Indicator (2025) Figure
People who developed TB 10.6 million
TB deaths About 1.1 million
Fall in deaths since 2015 35%
Fall in incidence since 2015 14%
People diagnosed 8.4 million
Missed or unreported cases About 2.2 million
Rifampicin-resistant TB cases About 370,000
Domestic TB funding US$5.6 billion

India’s Progress on TB Deaths

Business Standard, citing the report, said India’s estimated TB death rate fell from 280 per million people in 2015 to 180 per million in 2025. That puts India’s decline ahead of the global average.

Union Health Minister JP Nadda welcomed the findings in a post on X, saying India’s fight against TB “is showing encouraging results”. He credited technology, community participation and patient-centred care for the gains.

The Health Ministry also listed what it achieved under the TB Mukt Bharat Abhiyaan:

  • More than 25 crore people covered under intensified screening
  • Over 11 crore chest X-rays and more than 3 crore molecular tests carried out
  • 48.64 lakh TB cases detected, including nearly 15 lakh people with no symptoms
  • A treatment success rate of 94%
  • Nutrition support through the Ni-kshay Poshan Yojana and help from Ni-kshay Mitra volunteers

WHO also noted that 96% of India’s TB programme funding needs are met from domestic resources, which matters at a time when international aid for TB has been shrinking.

Why India Still Carries the Biggest Burden

The good news on deaths does not change India’s position at the top of the table. India accounted for about 25% of all TB cases worldwide in 2025. The eight countries with the most cases together made up 67% of the global total.

Country Share of global TB cases (2025)
India 25%
Indonesia 10%
Philippines 6.8%
China 6.5%
Pakistan 6.4%
Nigeria 4.9%
DR Congo 3.9%
Bangladesh 3.7%

India is also one of four countries that together account for more than half of the world’s multidrug-resistant TB cases, although both WHO and the Health Ministry say MDR-TB incidence in India is slowly declining.

WHO said India’s TB profile will be reviewed once district-level surveillance data is analysed. A national prevalence survey by ICMR’s National Institute for Research in Tuberculosis was shared with WHO this year, and WHO expects to update its incidence trend estimates in early 2027.

Funding Gaps and Drug Resistance Worry WHO

Globally, domestic funding for TB rose 14% between 2024 and 2025 to US$5.6 billion. WHO said this partly made up for a similar drop in international money. Research funding, however, stood at only US$1.2 billion in 2023, less than a quarter of the US$5 billion yearly target set for 2027.

Testing and treatment gaps remain large. Only 59% of newly diagnosed patients were tested with a WHO-recommended rapid test, while the target is 100% by 2027. Of the roughly 370,000 people who developed rifampicin-resistant TB, only 42% received treatment.

On the same day, WHO urged countries in its South-East Asia Region, which includes India, to speed up efforts. ANI reported that the region carries about 38% of the global burden of drug-resistant TB, with an estimated 140,000 people developing these forms of the disease.

What Comes Next for TB Mukt Bharat

The Health Ministry has said it will keep up intensified screening, expand diagnostics and preventive treatment, and continue nutrition support and community programmes. For patients and families, the main message is that free testing and treatment are available through government health facilities, and early diagnosis makes a cure far more likely. Readers following other WHO warnings this month can also see our report on WHO treating El Nino as a health emergency.

India’s 38% fall in deaths shows that wider screening and better care are working. The harder task is bringing down the number of new infections, which will decide whether the country, and the world, can end TB as a public health threat.

This article is for general information only and is not medical advice. Please consult a qualified doctor for diagnosis or treatment.

More Health News